College of Veterinary Medicine / University of Mosul
  • Register
  • Login
  • العربیة

Iraqi Journal of Veterinary Sciences

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 36, Issue Supplement I
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Immune response strategies of Brucella melitensis and their antigens in rats

    Basher S. Noomi Sanaa S. Ahmed Hiba Y. Khalaf Nihad A. Jafar

Iraqi Journal of Veterinary Sciences, 2022, Volume 36, Issue Supplement I, Pages 27-30
10.33899/ijvs.2022.134990.2431

  • Show Article
  • Highlights
  • Full Text
  • References
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Brucella melitensis is an intracellular bacterium and is the main brucella species that cause abortion and placenta retention in sheep and goats. It has many mechanisms to evade the immune response. The current study aimed to investigate Brucella melitensis strategies for producing immune responses in rats after challenging the bacterium. For this purpose, live and killed Brucella melitensis REV1 strain was given to rats subcutaneously, and immunological markers like TLR2, TLR4, IFN- γ, and anti-brucella antibodies were determined. The results showed that the level of immunological markers like TLR2 and TLR4 did not significantly increase in rat groups inoculated with live Brucella melitensis, while it increased in the rats’ groups vaccinated with the sonicated Brucella melitensis; also, the results showed an increase in the level of IFN-γ and anti-brucella antibody titers in all animal groups. The study concluded that the inoculation with killed bacteria and REV1 could protect the animals against challenging doses, as seen when the groups were inoculated with challenge dose of the bacterium.
Keywords:
    Brucella melitensis Immune response REV1
Main Subjects:
  • Veterinary Microbiology

Introduction

 

Brucella is gram negative intracellular zoonotic bacteria, that causes many diseases to human and animals (1). Brucella melitensis is the main Brucella species that caused abortion and placenta retention in sheep and goats (2). Live attenuated and killed vaccines were used for the protection of animals and humans. REV1 vaccine which is prepared from live attenuated Brucella melitensis strain is the main vaccine types used for sheep and goat’s protective against brucellosis (3). The protective effects of the REV1 vaccine are due to the stimulation of T- helper and T-cytotoxic with their mediators (3,4). Both cellular and humoral immune responses were activated after Brucella infection or vaccination with a live and killed vaccine (5). Innate immunity plays an important role in host protection against Brucella by activation of neutrophil and NK cells. Both macrophages and dendritic cells play an important role as antigens presenting cells which consider the key to immune responses (6,7). Toll-like receptors (TLRs) recognized pathogen associated molecular patterns (PAMPs), which lead to the activation of dendritic cells and produce proinflammatory cytokines (8). They are 13 types of TLR in rats. Bacterial compounds such as LPS, flagella and lipopeptide will be recognized by TLR2, TLR4, TLR5, and TLR9 (9). Both TLR2 and TLR4 can recognized bacterial components and are considered triggers to adaptive immune response. Brucella can evade immune system mechanism by many pathways this activity prevents both TLR2 (outer membrane proteins) and TLR4 (lipopolysaccharide) from activation (10,11). Cellular immune responses against Brucella and other intracellular pathogen involve activation of CD4 and CD8 T-cells, host Protection occurs by Th1 mediated, interferon-γ (IFN-γ) which is an important cytokine of Th1 that stimulate of macrophages (12). The Aim of the study was to investigate the ability of live and killed Brucella melitensis and REV1 to produce immune response and to protect the animal from infection.

 

Materials and methods

 

Ethical approve

Experiments were performed on laboratory animals after obtaining the approval of the Scientific Committee at the College of Veterinary Medicine, University of Tikrit.

 

Pathogenic Brucella melitensis isolates

The pathogenic Brucella melitensis isolates were isolated from aborted goats, bacterial isolation was conducted by using of Trypton soya broth (Himedia, India) as transport media and brucella basel agar (Biolive, Italy) was used and 5% of sterile horse blood was added to the agar and one ampule of Brucella selective supplement (Himedia, India) was added for each 500 ml of media for the isolation of Brucella melitensis, each sample inoculated in two agar plates, one inoculated aerobically and other inoculated un aerobically, gram stain and biochemical tests were applied according to Alton et al. (13). The isolated consider as Brucella melitensis if grow aerobically and un aerobically as pearl white colonies, appear as gram negative coccobacilli, positive to oxidase, catalase and urease test (13).

 

Vaccine isolates

Brucevac, Jovac, Jordan which contain 5*108 CFU/ml viable live attenuated Brucella melitensis Rev1 strain, according to results of LD50.

 

Whole Sonicated Brucella melitensis

Prepared by using of ultra-sonicator (Karl Klob, Germany) at 12 Peak with 2 minutes intervals between them, for 30 minutes in a cold environment (ice) according to Mitove et al. (14).

 

Experimental animals

Adult male rats at age of three months and weight 150-180 grams were housed in the animal house, Tikrit University, College of Veterinary Medicine.

 

Experimental animals grouping

four groups, 8 rats in each group. First group, were inoculated subcutaneously with pathogenic Brucella melitensis in a dose of 0.25 ml from bacterial suspension of concentration 105 CFU/ml. Second group, were inoculated subcutaneously with REV1 in a dose of 105 CFU/ml. Third group, were inoculated with 2 milligrams of Whole Sonicated Brucella melitensis (after dissolving with phosphate buffer saline). Fourth group, negative control inoculated with 1ml of phosphate buffer saline. After 21 days, 2-3 ml of blood were collected and serum separated to determine of immunomarkers such as TLR2, TLR4 and IFNγ and antibodies titer.

 

Immunological marker

TLR4 determined in serum by using of Rat toll-like receptor 4 (TLR4) Sandwich ELISA Kit (CUSABIO- USA) the results calculated by OD and standard curve method for evaluation. TLR2 determined in serum by using of Rat Toll Like Receptor 2 (TLR-2) Sandwich ELISA Kit- (MYBIOSOURCE- USA) the results calculated by OD and standard curve method for evaluation. Rat IFN-gamma quantizing Sandwich ELISA kit (BIO TECH- usa) the results calculated by OD and standard curve method for evaluation.

 

Antibody titer

Anti-Brucella melitensis antibodies titer was determined by Tube agglutination test by use of kit of Brucella melitensis antigen (Febrile Serodiagnostic - LINEAR CHEMICALS- SPAIN).

 

Challenge dose

After 30 days of the first treatment, all animal groups were inoculated subcutaneously with 1ml of 106 CFU/ml pathogenic Brucella melitensis, then the animals were observed for 14 days and any clinical singes or death were recorded.

 

Statistical analyses

Conducted by version 9.1 of the SPSS program. one-way Variance Analysis (ANOVA) were used, least significant difference (LSD) test to detect the differences among means. P<0.05.

 

Results

 

The result of the ELSA test shows significant increase in levels of TLR2 and TLR4 in the group Vaccinated Whole Sonicated Brucella melitensis in compare with other groups as in table 1. Also, the current study showed a significant increase in IFN-γ and antibody titer in all treated groups in comparison with the control group. The result of challenge dose in rats showed that high ability of REV1 vaccine and previous infection in protection of rats against recurrent infection with Brucella melitensis as appeared in group 1 and 2, since only 12.5% of animals dead in case of group 2 (inoculated with live bacteria), while no dead were seen in group 1 (REV1 group).

 

Table 1: TLR2, TLR4, IFN-γ and antibodies titer in the studied groups

 

Animal groups

TLR2

TLR4

Gamma interferon

Antibody titer

Group 1

22±2.76b

101±3.1b

680±39.1d

400 (640-160) d

Group 2

22±3.5b

98±2.7b

530±24.7c

260 (320-160) b

Group 3

29±1.9c

118±2.9c

470+38.7b

320 (640-160) c

Group 4

20±2.51a

94.2±7.1a

300±21.3a

0

Difference letters refer to significant difference in P≤0.05

 

Discussion

 

Many studies mentioned that bacteria become resistant to many commonly used antibiotics (15,16); therefore, it is important to protect animals from infection through vaccination. Brucellosis is an endemic disease in many countries of the Middle East including Iraq, despite the high attempts to control the disease in animals using vaccination programs (17,18). In the current study, a local bacterial isolate was used in order to induce an immune response in laboratory animals in addition to the REV1 vaccine. The result showed significant increase in levels of TLR2 and TLR4 in group Vaccinated Whole Sonicated Brucella melitensis when compared with other groups. These results agreed with Solanki et al. (19). Detection of Brucella by Toll-like receptors (TLRs) is an essential activation step in innate immune response, Brucella escaped from innate immunity mechanisms, by using hydrophobicity phenomena of Brucella cell envelope, these phenomena delayed or reduced inflammatory response by minimizing pattern recognition receptors (such as TLR) stimulation of the host (20,21). TLR2 and TLR4 are involved in DC activation and maturation and the absence of TLR2 and 4 significantly reduced the expression of the maturation markers in DC (22). The current study noted that TLR2 and TLR4 increase only in the group that is immunized with whole Sonicated Brucella melitensis which lose their ability to escape from innate immunity mechanisms. The lower antigenicity of Brucella smooth lipopolysaccharides (such as Brucella melitensis) to induce NOS-2 and COX-2 leads to lower activation ability of monocyte chemoattractant protein-1 (MCP-1) and macrophage-inflammatory protein that’s lead to reduce the production of pro-inflammatory cytokines (23,24). The highly protective ability of REV1 in comparison with Sonicated antigen due to the ability of the REV1 vaccine to stimulate both humeral and cellular immune responses (25). The presence of one animal out of 8 animals in the control group not dying, may be due to individual variation in the ability of immune response of animals.

 

Conclusion

 

Brucella melitensis has ability to escape from innate immune response, so that TLR2 and TLR4 levels not increase, live and killed Brucella melitensis caused an increase in antibody and IFN-γ levels and protect experimental animal when challenged with pathogenic Brucella melitensis.

 

Acknowledgments

 

Thanks to all members of the microbiology Department, College of Veterinary Medicine, Tikrit University, for their valuable efforts and advice.

 

Conflict of interest

 

 The authors declare that there is no conflict of interest

1-    Sonicated Brucella melitensis can cause an increase in antibody and IFN-γ levels and protect experimental animal.

2-    TLR2 and TLR4 are good immunological markers to study the immune responses against Brucella melitensis.

3-    REV1 vaccine is very efficient in inducing immunity to Brucella.

  • PDF (653 K)
  • XML
(2022). Immune response strategies of Brucella melitensis and their antigens in rats. Iraqi Journal of Veterinary Sciences, 36(Supplement I), 27-30. doi: 10.33899/ijvs.2022.134990.2431
Basher S. Noomi; Sanaa S. Ahmed; Hiba Y. Khalaf; Nihad A. Jafar. "Immune response strategies of Brucella melitensis and their antigens in rats". Iraqi Journal of Veterinary Sciences, 36, Supplement I, 2022, 27-30. doi: 10.33899/ijvs.2022.134990.2431
(2022). 'Immune response strategies of Brucella melitensis and their antigens in rats', Iraqi Journal of Veterinary Sciences, 36(Supplement I), pp. 27-30. doi: 10.33899/ijvs.2022.134990.2431
Immune response strategies of Brucella melitensis and their antigens in rats. Iraqi Journal of Veterinary Sciences, 2022; 36(Supplement I): 27-30. doi: 10.33899/ijvs.2022.134990.2431
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver

  1. Almashhadany DA. Diagnosis of brucellosis in sheep and goats’ raw milk by fast and reliable techniques. Iraqi J Vet Sci. 2021;35(4):663-668.‏ DOI: 10.33899/ijvs.2021.127697.1523
  2. Saravanan S, Saravanajeyam M, Palanivel KM. Molecular detection of Brucella melitensis in mecheri sheep. Indian J Small Ruminants. 2021;27(2):297-300.‏ DOI: 10.5958/0973-9718.2021.00046.5
  3. Goncagul G, Gunaydin E, Kardogan O, Cokal Y, Salci ES. REV-1 conjunctival vaccine administration in Turkey. Med. Weter. 2021;77(11):538-540.‏ DOI: www.doi.org/10.21521/mw.6582
  4. Doshi AS, Asrani KH. Innate and adaptive immunity in cancer. NY: Academic Press; 2010.‏
  5. Shirdast H, Ebrahimzadeh F, Taromchi AH, Mortazavi Y, Esmaeilzadeh A, Sekhavati MH, Nedaei K, Mirabzadeh E. Recombinant Lactococcus lactis displaying Omp31 antigen of Brucella melitensis can induce an immunogenic response in BALB/c mice. Probiotics Antimicrob Proteins. 2021;13(1):80-89. [available at]
  6. Kubelkova K, Macela A. Francisella and Antibodies. Microorganisms. 2021;9(10):2136.‏ 10.3390/microorganisms9102136
  7. Al-Dabagh II, Jasim BM, Jarjees MT. Seroprevalence of antibodies to toxoplasmosis, brucellosis and chlamydiosis in abortive sheep in Nineveh governorate, Iraq. Iraqi J Vet Sci. 2014;28(1):21-25. DOI: 10.33899/ijvs.2014.89467
  8. 8- Jin S, Nepal N, Gao Y. The role of toll-like receptors in peptic ulcer disease. Immunol Med. 2022;45(2):69-78.‏ DOI: 10.1080/25785826.2021.1963190
  9. 9- Xia P, Wu Y, Lian S, Yan L, Meng X, Duan Q, Zhu G. Research progress on Toll-like receptor signal transduction and its roles in antimicrobial immune responses. App Microbiol Biotechnol. 2021;105(13):5341-5355.‏ DOI: 10.1007/s00253-021-11406-8
  10. 10- Tiku V, Tan MW. Host immunity and cellular responses to bacterial outer membrane vesicles. Trends Immunol.‏ 2021;42(11):1024-1036. DOI: 10.1016/j.it.2021.09.006
  11. Mirzaei R, Sholeh M, Jalalifar S, Zafari E, Kazemi S, Rasouli- A, Karampoor S, Youse R. Immunometabolism in human brucellosis: An emerging field of investigation. Microb Pathog. 2021;158:105115.‏ DOI: 10.1016/j.micpath.2021.105115
  12. 12- Priyanka, Shringi BN, Choudhary OP, Kashyap SK. Cytokines in brucellosis: biological rhythm at the interface of innate and adaptive immunity. Biol Rhythm Res. 2021;52(7):1031-1043. DOI: 10.1080/09291016.2019.1613794
  13. Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis. 2nd ed. Geneva: World Health Organization;1975.
  14. Mitov I, Denchev V, Linde K. Humoral and cell-mediated immunity in mice after immunization with live oral vaccines of Salmonella typhimurium: auxotrophic mutants with two attenuating markers. Vaccine. 1992;10(1):61-66. DOI: 10.1016/0264-410X(92)90421-F
  15. Shireen A. Yousif; Dhyaa Mohammad Taher Jwher. Detection of multiple presence of antibiotic residues in slaughtered sheep at Duhok abattoir, Iraq. Iraqi J Vet Sci. 2021;35(1):49-55. DOI: 10.33899/ijvs.2019.126259.1276
  16. Hala MM, Heba YK, Halah AA, Bashar SN. Evaluation the safety and synergistic effect of NiFe2O4 nanoparticles with antibiotic against Pseudomonas aeruginosa. Iraqi J Vet Sci. 2021;35(1):71-77 DOI: 10.33899/ijvs.2020.126298.1294
  17. Al-Alo KZ, Mohammed AJ. A cross sectional study on the seroprevalence of bovine brucellosis in Al-Najaf province in Iraq. Iraqi J Vet Sci. 2021;35(4):617-620. DOI: 10.33899/ijvs.2021.127143.1471
  18. Kani M. Ridhae SA. Serological and molecular investigations of Brucellosis in dairy cows at certain areas of Al-Sulaymaniyah governorate- Iraq. Iraqi J Vet Sci. 2021;35(4):657-662. DOI: 10.33899/ijvs.2021.127688.1520
  19. Solanki KS, Varshney R, Qureshi S, Thomas P, Singh R, Agrawal A, Chaudhuri P. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge. Int Immunopharmacol. 2021;90:107148.‏ DOI: 10.1016/j.intimp.2020.107148
  20. Pan C, Yue H, Zhu L, Ma GH, Wang HL. Prophylactic vaccine delivery systems against epidemic infectious diseases. Adv Drug Deliv Rev. 2021;176:113867.‏ DOI: 10.1016/j.addr.2021.113867
  21. Arias MA, Santiago L, Costas-Ramon S, Jaime-Sánchez P. Toll-Like Receptors 2 and 4 cooperate in the Control of the Emerging Pathogen Brucella microti. Front Cell Infect Microbiol. 2017;6:1-9. DOI: 10.3389/fcimb.2016.0020 
  22. Jiao H, Zhou Z, Li B, Xiao Y, Li M, Zeng H, Guo X, Gu G. The mechanism of facultative intracellular parasitism of brucella. Int J Mol Sci. 2021;22(7):3673.‏ DOI: 10.3390/ijms22073673
  23. Zhu H, Rollier CS, Pollard AJ. Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Rev Vaccines. 2021;20(12):1-24. DOI: 10.1080/14760584.2021.1984889
  24. Ferrari D, la Sala A, Milani D, Celeghini C, Casciano F. Purinergic signaling in controlling macrophage and t cell functions during atherosclerosis development. Front Immunol. 2021;11:3800.‏ DOI: 10.3389/fimmu.2020.617804
  25. Hou H, Liu X, Peng Q. The advances in brucellosis vaccines. Vaccine. 2019;37(30):3981-3988.‏ DOI: 10.1016/j.vaccine.2019.05.084

  • Article View: 114
  • PDF Download: 75
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

© 2023, College of Veterinary Medicine, University of Mosul

 
Powered by eJournalPlus